Endogenous cannabinoid as a retrograde messenger from depolarized postsynaptic neurons to presynaptic terminals

被引:93
作者
Maejima, T [1 ]
Ohno-Shosaku, T [1 ]
Kano, M [1 ]
机构
[1] Kanazawa Univ, Sch Med, Dept Physiol, Kanazawa, Ishikawa 9208640, Japan
基金
日本科学技术振兴机构;
关键词
cannabinoid receptor; endocannabinoid; retrograde messenger; Ca2+; synaptic transmission; synaptic modulation;
D O I
10.1016/S0168-0102(01)00241-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cannabinoid receptors are the molecular targets for the active component Delta (9)-tetrahydrocannabinol of marijuana and hashish, and constitute a major family of G protein-coupled seven-transmembrane-domain receptors. They consist of type 1 (CBI) and type 2 (CB2) receptors of which the CB1 is rich in various regions of the CNS. Accumulated evidence suggests that endogenous cannabinoids function as diffusible and short-lived intercellular messengers that modulate synaptic transmission. Recent studies have provided strong experimental evidence that endogenous cannabinoids mediate signals retrogradely from depolarized postsynaptic neurons to presynaptic terminals to suppress subsequent neurotransmitter release, driving the synapse into an altered state. In hippocampal neurons, depolarization of postsynaptic neurons and resultant elevation of [Ca2+](i) lead to transient suppression of inhibitory transmitter release (depolarization-induced suppression of inhibition, DSI). In cerebellar Purkinje cells. on the other hand, depolarization-induced elevation of [Ca2+](i) causes transient suppression of excitatory transmitter release (depolarization-induced suppression of excitation. DSE). DSI and DSE appear to share the same properties and may be a general and important mechanism by which the postsynaptic neuronal activity can influence the amount of transmitter release. (C) 2001 Elsevier Science Ireland Ltd and the Japan Neuroscience Society. All rights reserved.
引用
收藏
页码:205 / 210
页数:6
相关论文
共 56 条
[41]  
PITLER TA, 1992, J NEUROSCI, V12, P4122
[42]  
PLOMELLI D, 2000, TRENDS PHARMACOL SCI, V21, P218
[43]  
Shen MX, 1996, J NEUROSCI, V16, P4322
[44]   A second endogenous cannabinoid that modulates long-term potentiation [J].
Stella, N ;
Schweitzer, P ;
Piomelli, D .
NATURE, 1997, 388 (6644) :773-778
[45]   2-ARACHIDONOYLGYLCEROL - A POSSIBLE ENDOGENOUS CANNABINOID RECEPTOR-LIGAND IN BRAIN [J].
SUGIURA, T ;
KONDO, S ;
SUKAGAWA, A ;
NAKANE, S ;
SHINODA, A ;
ITOH, K ;
YAMASHITA, A ;
WAKU, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 215 (01) :89-97
[46]   Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor - Structure-activity relationship of 2-arachidonoylglycerol ether-linked analogues, and related compounds [J].
Sugiura, T ;
Kodaka, T ;
Nakane, S ;
Miyashita, T ;
Kondo, S ;
Suhara, Y ;
Takayama, H ;
Waku, K ;
Seki, C ;
Baba, N ;
Ishima, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (05) :2794-2801
[47]  
Thomas EA, 1997, J NEUROSCI RES, V50, P1047, DOI 10.1002/(SICI)1097-4547(19971215)50:6<1047::AID-JNR16>3.0.CO
[48]  
2-1
[49]   Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system [J].
Tsou, K ;
Brown, S ;
Sañudo-Peña, MC ;
Mackie, K ;
Walker, JM .
NEUROSCIENCE, 1998, 83 (02) :393-411
[50]   Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing gabaergic interneurons in the rat hippocampal formation [J].
Tsou, K ;
Mackie, K ;
Sañudo-Peña, MC ;
Walker, JM .
NEUROSCIENCE, 1999, 93 (03) :969-975